Granules India Limited — Updates, 17-12-2024: Press Release
17-12-2024 | 11:06 am
17-12-2024 | 11:06 am
Granules India Limited has informed the Exchange regarding a press release dated December 17, 2024, titled "Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.".
No comments yet. Be the first to comment!
